Annual Total Liabilities
$16.51 M
+$3.48 M+26.75%
December 31, 2023
Summary
- As of February 7, 2025, PBLA annual total liabilities is $16.51 million, with the most recent change of +$3.48 million (+26.75%) on December 31, 2023.
- During the last 3 years, PBLA annual total liabilities has risen by +$15.15 million (+1109.67%).
- PBLA annual total liabilities is now at all-time high.
Performance
PBLA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$23.34 M
+$3.35 M+16.79%
September 30, 2024
Summary
- As of February 7, 2025, PBLA quarterly total liabilities is $23.34 million, with the most recent change of +$3.35 million (+16.79%) on September 30, 2024.
- Over the past year, PBLA quarterly total liabilities has increased by +$6.82 million (+41.33%).
- PBLA quarterly total liabilities is now at all-time high.
Performance
PBLA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
PBLA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.8% | +41.3% |
| 3 y3 years | +1109.7% | +67.4% |
| 5 y5 years | +913.0% | +67.4% |
PBLA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +520.8% | at high | +777.3% |
| 5 y | 5-year | at high | +1109.7% | at high | +1681.4% |
| alltime | all time | at high | +2433.3% | at high | +4002.7% |
Panbela Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $23.34 M(+16.8%) |
| Jun 2024 | - | $19.98 M(+45.7%) |
| Mar 2024 | - | $13.71 M(-17.0%) |
| Dec 2023 | $16.51 M(+26.8%) | $16.51 M(+25.9%) |
| Sep 2023 | - | $13.11 M(-11.1%) |
| Jun 2023 | - | $14.75 M(+5.8%) |
| Mar 2023 | - | $13.94 M(+7.0%) |
| Dec 2022 | $13.03 M(+389.7%) | $13.03 M(-0.9%) |
| Sep 2022 | - | $13.15 M(+15.4%) |
| Jun 2022 | - | $11.39 M(+152.8%) |
| Mar 2022 | - | $4.51 M(+69.4%) |
| Dec 2021 | $2.66 M(+94.9%) | $2.66 M(+98.7%) |
| Sep 2021 | - | $1.34 M(-3.9%) |
| Jun 2021 | - | $1.39 M(+6.3%) |
| Mar 2021 | - | $1.31 M(-4.0%) |
| Dec 2020 | $1.36 M(-22.4%) | $1.36 M(-29.5%) |
| Sep 2020 | - | $1.94 M(+12.4%) |
| Jun 2020 | - | $1.72 M(+22.0%) |
| Mar 2020 | - | $1.41 M(-19.7%) |
| Dec 2019 | $1.76 M(+7.9%) | $1.76 M(+22.9%) |
| Sep 2019 | - | $1.43 M(-1.7%) |
| Jun 2019 | - | $1.46 M(-41.7%) |
| Mar 2019 | - | $2.50 M(+53.3%) |
| Dec 2018 | $1.63 M | $1.63 M(+9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $1.49 M(+3.2%) |
| Jun 2018 | - | $1.44 M(-65.2%) |
| Mar 2018 | - | $4.14 M(-7.0%) |
| Dec 2017 | $4.46 M(-19.3%) | $4.46 M(+22.7%) |
| Sep 2017 | - | $3.63 M(+28.2%) |
| Jun 2017 | - | $2.83 M(+6.1%) |
| Mar 2017 | - | $2.67 M(-51.6%) |
| Dec 2016 | $5.52 M(+25.1%) | $5.52 M(+7.1%) |
| Sep 2016 | - | $5.15 M(+7.7%) |
| Jun 2016 | - | $4.78 M(-3.5%) |
| Mar 2016 | - | $4.96 M(+12.3%) |
| Dec 2015 | $4.41 M(+16.3%) | $4.41 M(+9.5%) |
| Sep 2015 | - | $4.03 M(+608.5%) |
| Jun 2015 | - | $568.80 K(-11.3%) |
| Mar 2015 | - | $641.00 K(-83.1%) |
| Dec 2014 | $3.79 M(+466.1%) | $3.79 M(+463.3%) |
| Sep 2014 | - | $673.50 K(+0.5%) |
| Jun 2014 | - | $670.00 K(-1.6%) |
| Mar 2014 | - | $680.90 K(+1.6%) |
| Dec 2013 | $670.20 K(+2.8%) | $670.20 K(+1.5%) |
| Sep 2013 | - | $660.00 K(+0.9%) |
| Jun 2013 | - | $654.30 K(-0.7%) |
| Mar 2013 | - | $658.90 K(+1.1%) |
| Dec 2012 | $651.80 K(-1.1%) | $651.80 K |
| Dec 2011 | $658.80 K | - |
FAQ
- What is Panbela Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Panbela Therapeutics?
- What is Panbela Therapeutics annual total liabilities year-on-year change?
- What is Panbela Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly total liabilities year-on-year change?
What is Panbela Therapeutics annual total liabilities?
The current annual total liabilities of PBLA is $16.51 M
What is the all time high annual total liabilities for Panbela Therapeutics?
Panbela Therapeutics all-time high annual total liabilities is $16.51 M
What is Panbela Therapeutics annual total liabilities year-on-year change?
Over the past year, PBLA annual total liabilities has changed by +$3.48 M (+26.75%)
What is Panbela Therapeutics quarterly total liabilities?
The current quarterly total liabilities of PBLA is $23.34 M
What is the all time high quarterly total liabilities for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly total liabilities is $23.34 M
What is Panbela Therapeutics quarterly total liabilities year-on-year change?
Over the past year, PBLA quarterly total liabilities has changed by +$6.82 M (+41.33%)